DOI : 10.1055/s-00000041

Neuropediatrics

Issue 01 · Volume 35 · February 2004 DOI: 10.1055/s-002-3101


Abstracts for the 30th Annual Meeting of the Society for Neuropediatrics (Gesellschaft für Neuropädiatrie)
Bern, Switzerland, March 25–28, 2004

M. Steinlin
Abstracts (HTML) List of Authors
P1
Kudernatsch, V.; Kluger, G.: St Valentine – patron saint of epilepsy – illustrating the semiology of childhood seizures over ther course of six centuries
P2
Wohlrab, G.; Uyanik, G.; Gross, C.; Hehr, U.; Schmitt, B.; Boltshauser, E.: Familial West syndrome and dystonia caused by ARX gene mutation
P3
Roschitz, B.; Gruber-Sedlmayr, U.; Claes, L.; De Jonghe, P.; Plecko, B.: SCN1A gene mutations in two patients with severe infantile epileptic encephalopathy
P5
Sälke-Kellermann, R.; Weissert, M.; Dorn, T.: Epilepsy in children with inv dup(15)
P6
Fuchs, K.; Urak, L.; Sieghart, W.; Feucht, M.: Mutation screen of the GABAA receptor beta3 subunit gene in patients with childhood absence epilepsy
P7
Datta, A. N.; Lütschg, J.; Weber, P.: DOPA responsive dystonia and myoclonic epilepsy: case report on an unusual combination of symptoms
P8
Völkl-Kernstock, S.; Willinger, U.; Feucht, M.: Cognitive disabilities of children with a benign partial epilepsy
P9
Baumeister, F. A. M.; Liebhaber, G.; Oberhoffer, R.; Gempel, K.; Freisinger, P.; Holthausen, H.: Fatal propofol infusion syndrome in association with ketogenic diet in a child with catastrophic epilepsy
P10
Jourdan Moser, S.; Lütschg, J.: EEG characteristics in Rett syndrome
P11
Liebhaber, G.; Baumeister, F. A. M.; Gempel, K.: Carnitine deficiency in children with pharmacoresistant epilepsy during treatment with ketogenic diet
P12
Liebhaber, G.; Baumeister, F. A. M.: Quality of life of children with pharmacoresistant epilepsy on ketogenic diet
P13
Bruhn, K.; Rinnert, S.; Stephani, U.: Paroxysmal dystonic choreoathetosis
P14
Shamdeen, M. G.; Frohnhöfer, M.; Jost, W.; Weber, R.; Rohrer, T.: Rolandic epileptiform discharges in children with minimal cerebral disorders: is a therapy with sulthiame indicated?
P15
Schreiner, A.; Wheless, J.; Wang, S.: Monotherapy in newly diagnosed epilepsy: findings in the pediatric subset of a comparative study of topiramate, carbamazepine, and valproate
P16
Schreiner, A.: Efficacy and tolerability of topiramate in children and adolescents with partial or primary generalized epilepsy
P17
Werner, T.; Schulze, A.; König, S.: Influence of valproate, carbamazepine and antiepileptic polytherapy on free carnitine in pediatric patients
P18
Berg, J.; Kluger, G.; Redbrake, A.; Holthausen, H.: Ethosuximide is the drug of choice against epileptic negative myoclonus (ENM)
P19
Gerstner, T.; Demirakca, T.; Göppel, C.; Sungurtekin, I.; Brauss, D. F.; König, S. A.: Functional-MRI for school-aged children with neonatal phenobarbitone medication
P20
Feucht, M.; Hoffmann, K.; Benninger, F.; Möller, U.; Witte, H.: Ictal and interictal nonlinear EEG-dynamics measured with the point prediction error (PPE) in children with temporal lobe epilepsy (TLE)